BS
Therapeutic Areas
Ensysce Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PF614 | Management of severe pain | Phase 2 |
| PF614-MPAR | Management of severe pain with overdose protection | Phase 2 |
| PF650 | Management of severe pain in opioid-tolerant patients | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| PF614 | Management of severe pain | Phase 2 |
| PF614-MPAR | Management of severe pain with overdose protection | Phase 2 |
| PF650 | Management of severe pain in opioid-tolerant patients | Phase 1 |